Smallcap Rapp(TM) to Feature NASV and PWRM

247MGI, Inc. (PINKSHEETS: TOFS) ("247MGI") is pleased to announce that Smallcap Rapp(TM) will feature Robert W. Chance, CEO for National Automation Services, Inc. (PINKSHEETS: NASV), Monday May 19, 2008 at 1:00 PM EST, Steven Rash, CEO for Power3 Medical Products, Inc. (OTCBB: PWRM), Wednesday May 21, 2008 at 1:00 EST, and a third company for Friday May 23, 2008 to be named later.

About National Automation Services

From Hand Production to Automation

Before the Industrial Revolution, virtually all goods were made by hand. With the Industrial boom of the 1900s, the automation and controls industry was born to improve the quality and reduce the costs of tedious, repetitive tasks in the industrial plants.

Immediately after World War II, computers were born, almost entirely for scientific purposes. By the early 60s, computers began to make their way rapidly into process control and production. Automated assembly lines took on more and more tasks, allowing for an increasing number of automated processes and adjustments. By eliminating tedious tasks usually performed by hand, the owners of a plant realized higher quality and more output which improved not only quality but competitiveness as well.

About Power3 Medical Products

Power3 Medical Products, Inc. (OTCBB: PWRM) (www.Power3Medical.com), is a leading proteomics company engaged in the commercialization of protein biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets for cancer and neurodegenerative diseases. Power3's patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, identify protein biomarkers, and drug targets. Diagnostic tests are targeted toward markets with critical unmet needs in areas such as breast cancer and neurodegenerative disease. Power3 has signed its first distribution agreement to provide its blood serum diagnostic for breast cancer, BC-SeraPro(TM), in twelve Middle Eastern countries before the end of 2007. Power3 operates a state-of-the-art CLIA certified proteomics laboratory in The Woodlands (Houston), Texas. The Company is preparing to commercialize its IP portfolio, centering on the 543 biomarkers the Company has discovered from a broad range of diseases as the basis of blood-based tests for breast cancer, ALS, Alzheimer's, and Parkinson's Diseases.

About Smallcap Rapp(TM)

Smallcap Rapp(TM) is a one hour live interactive show between its guests and the listening audience. Listeners can call into the show and interact LIVE with the company or they can IM or email questions to the host who will then ask the questions and the company will respond LIVE on the air.

To contact the show please visit www.smallcaprapp.com you can register for the chat room and interact with other listeners, or you can email questions regarding the upcoming show to listener@247mgi.com.

The foregoing press announcement contains forward-looking statements that can be identified by such terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. In particular, management's expectations could be affected by, among other things, uncertainties relating to our success in completing acquisitions, financing our operations, entering into strategic partnerships, engaging management and other matters disclosed by us in our public filings from time to time. Forward-looking statements speak only as to the date they are made. The Company does not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.